C8 Medisensors, a US-based company specialising in glucose monitoring, secured $24m in series C funding on Thursday from investors including General Electric’s GE Capital financial services division and its GE Healthcare division, which made the investment through its Healthymagination fund.

C8 stated that GE joined existing investors in the round, but did not disclose the identity of the backers. C8 has now raised about $74.5m, according to Global Corporate Venturing estimates from the company’s Securities and Exchange Commission filings.


Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?